FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2220692989> ?p ?o ?g. }

• W2220692989 endingPage "280" @default.
• W2220692989 startingPage "273" @default.
• W2220692989 abstract "Better treatment outcomes in cystic fibrosis (CF) may be expected by changing standard twice daily (BID) tobramycin inhalation with the conventional nebulizer to once daily (OD) inhalation at double the standard BID dose with a controlled-inhalation nebulizer. We aimed to determine the pharmacokinetics and tolerability of inhaled double-dose tobramycin with the controlled-inhalation AKITA(®) and conventional PARI-LC(®) Plus nebulizer in patients with CF.Randomized, open label, crossover study. Pharmacokinetics were assessed in 10 adult CF patients following inhalation of tobramycin (Bramitob(®)) at double the recommended BID dose with the AKITA (300 mg fill dose) and PARI-LC Plus (600 mg fill dose).No significant differences were found in pharmacokinetic parameters between the two nebulizers. Median maximum serum levels were 3.44 (2.25-5.49) and 2.84 (0.82-6.63) mg/L for AKITA and PARI-LC Plus, respectively. Trough serum levels were very low for both nebulizers: 0.03 (0.00-0.09) and 0.02 (0.00-0.06) mg/L for AKITA and PARI-LC Plus, respectively. Time to maximum level was comparable: 0.44 (0.08-0.96) and 0.40 (0.08-0.96) hours for AKITA and PARI-LC Plus, respectively. Serum levels were well below the toxic limit. Inhalations were well tolerated and no serious adverse events occurred. Nebulization time was 33% shorter with the AKITA.OD tobramycin inhalation of the double standard BID dose with a controlled-inhalation and conventional nebulizer resulted in similar pharmacokinetics in the doses given, with serum levels below the toxic limit. Further research demonstrating clinical efficacy and safety of this treatment approach is required. Dutch trial register number NTR4525." @default.
• W2220692989 created "2016-06-24" @default.
• W2220692989 creator A5018163150 @default.
• W2220692989 creator A5022116804 @default.
• W2220692989 creator A5026591993 @default.
• W2220692989 creator A5038889546 @default.
• W2220692989 creator A5053308496 @default.
• W2220692989 creator A5079802068 @default.
• W2220692989 date "2016-06-01" @default.
• W2220692989 modified "2023-09-26" @default.
• W2220692989 title "Pharmacokinetics and Tolerability of Once Daily Double Dose Tobramycin Inhalation in Cystic Fibrosis Using Controlled and Conventional Nebulization" @default.
• W2220692989 cites W1975806439 @default.
• W2220692989 cites W1984893629 @default.
• W2220692989 cites W1990483077 @default.
• W2220692989 cites W1993019338 @default.
• W2220692989 cites W2023174165 @default.
• W2220692989 cites W2027180500 @default.
• W2220692989 cites W2030602816 @default.
• W2220692989 cites W2034055729 @default.
• W2220692989 cites W2056934536 @default.
• W2220692989 cites W2058225831 @default.
• W2220692989 cites W2070693357 @default.
• W2220692989 cites W2070698734 @default.
• W2220692989 cites W2079174073 @default.
• W2220692989 cites W2080477062 @default.
• W2220692989 cites W2096484542 @default.
• W2220692989 cites W2097575804 @default.
• W2220692989 cites W2099449365 @default.
• W2220692989 cites W2100739350 @default.
• W2220692989 cites W2116604032 @default.
• W2220692989 cites W2118312152 @default.
• W2220692989 cites W2119178074 @default.
• W2220692989 cites W2120857717 @default.
• W2220692989 cites W2125078269 @default.
• W2220692989 cites W2130690521 @default.
• W2220692989 cites W2133990815 @default.
• W2220692989 cites W2139226586 @default.
• W2220692989 cites W2139544998 @default.
• W2220692989 cites W2155063897 @default.
• W2220692989 cites W2156528332 @default.
• W2220692989 cites W2321958627 @default.
• W2220692989 cites W2406517758 @default.
• W2220692989 cites W2462092181 @default.
• W2220692989 doi "https://doi.org/10.1089/jamp.2015.1259" @default.
• W2220692989 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26716357" @default.
• W2220692989 hasPublicationYear "2016" @default.
• W2220692989 type Work @default.
• W2220692989 sameAs 2220692989 @default.
• W2220692989 citedByCount "9" @default.
• W2220692989 countsByYear W22206929892017 @default.
• W2220692989 countsByYear W22206929892018 @default.
• W2220692989 countsByYear W22206929892019 @default.
• W2220692989 countsByYear W22206929892020 @default.
• W2220692989 countsByYear W22206929892021 @default.
• W2220692989 countsByYear W22206929892022 @default.
• W2220692989 crossrefType "journal-article" @default.
• W2220692989 hasAuthorship W2220692989A5018163150 @default.
• W2220692989 hasAuthorship W2220692989A5022116804 @default.
• W2220692989 hasAuthorship W2220692989A5026591993 @default.
• W2220692989 hasAuthorship W2220692989A5038889546 @default.
• W2220692989 hasAuthorship W2220692989A5053308496 @default.
• W2220692989 hasAuthorship W2220692989A5079802068 @default.
• W2220692989 hasBestOaLocation W22206929892 @default.
• W2220692989 hasConcept C112705442 @default.
• W2220692989 hasConcept C126322002 @default.
• W2220692989 hasConcept C142724271 @default.
• W2220692989 hasConcept C185592680 @default.
• W2220692989 hasConcept C197934379 @default.
• W2220692989 hasConcept C204787440 @default.
• W2220692989 hasConcept C27081682 @default.
• W2220692989 hasConcept C2775832221 @default.
• W2220692989 hasConcept C2776938444 @default.
• W2220692989 hasConcept C2776954882 @default.
• W2220692989 hasConcept C2778375690 @default.
• W2220692989 hasConcept C2778974779 @default.
• W2220692989 hasConcept C2780352487 @default.
• W2220692989 hasConcept C42219234 @default.
• W2220692989 hasConcept C501593827 @default.
• W2220692989 hasConcept C55493867 @default.
• W2220692989 hasConcept C71924100 @default.
• W2220692989 hasConcept C87813604 @default.
• W2220692989 hasConcept C98274493 @default.
• W2220692989 hasConceptScore W2220692989C112705442 @default.
• W2220692989 hasConceptScore W2220692989C126322002 @default.
• W2220692989 hasConceptScore W2220692989C142724271 @default.
• W2220692989 hasConceptScore W2220692989C185592680 @default.
• W2220692989 hasConceptScore W2220692989C197934379 @default.
• W2220692989 hasConceptScore W2220692989C204787440 @default.
• W2220692989 hasConceptScore W2220692989C27081682 @default.
• W2220692989 hasConceptScore W2220692989C2775832221 @default.
• W2220692989 hasConceptScore W2220692989C2776938444 @default.
• W2220692989 hasConceptScore W2220692989C2776954882 @default.
• W2220692989 hasConceptScore W2220692989C2778375690 @default.
• W2220692989 hasConceptScore W2220692989C2778974779 @default.
• W2220692989 hasConceptScore W2220692989C2780352487 @default.
• W2220692989 hasConceptScore W2220692989C42219234 @default.
• W2220692989 hasConceptScore W2220692989C501593827 @default.
• W2220692989 hasConceptScore W2220692989C55493867 @default.

• next